Good morning :)
Place Order
Add to Watchlist

Biofil Chemicals and Pharmaceuticals Ltd

BIOFILCHEM Share Price

50.143.39% (-1.76)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹81 cr, stock is ranked 3,174

High Risk

Stock is 3.84x as volatile as Nifty

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹81 cr, stock is ranked 3,174

High Risk

Stock is 3.84x as volatile as Nifty

BIOFILCHEM Performance & Key Metrics

BIOFILCHEM Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
150.914.48—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.216.660.83%

BIOFILCHEM Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

BIOFILCHEM Company Profile

Biofil Chemicals and Pharmaceuticals Limited is engaged in pharmaceuticals and chemicals business. The Company is also engaged in manufacturing plastic products for the purpose of packing of pharmaceutical product and other plastic products.

BIOFILCHEM Similar Stocks (Peers)

Compare with peers Compare with peers 

BIOFILCHEM Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.38%
2.38%
Buy Reco %
74.19
74.19
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
56.67
56.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
72.00
72.00
Mankind Pharma Ltd
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
81.25
81.25
Compare with Peers

BIOFILCHEM Forecast

BIOFILCHEM Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

BIOFILCHEM

BIOFILCHEM

Income

Balance Sheet

Cash Flow

BIOFILCHEM Income Statement

BIOFILCHEM Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.78%, vs industry avg of 9.02%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.01%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 8.45%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue13.5912.4623.2329.8636.5522.5330.1440.5333.7133.71
Raw Materialssubtract8.5210.6919.8225.6535.2015.8727.6237.7832.5532.56
Power & Fuel Costsubtract0.440.330.370.490.290.300.330.38
Employee Costsubtract0.530.730.890.860.750.790.450.50
Selling & Administrative Expensessubtract0.860.530.720.780.370.370.540.56
Operating & Other expensessubtract0.48-0.860.300.09-2.463.72-0.080.00
Depreciation/Amortizationsubtract0.280.300.370.410.410.430.430.400.380.38
Interest & Other Itemssubtract0.160.150.160.120.070.040.040.040.040.04
Taxes & Other Itemssubtract0.520.120.120.260.670.320.230.150.180.19
EPS1.110.290.290.740.770.420.360.440.340.33
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

BIOFILCHEM Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

BIOFILCHEM Stock Peers

BIOFILCHEM Past Performance & Peer Comparison

BIOFILCHEM Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Biofil Chemicals and Pharmaceuticals Ltd145.524.48—
Sun Pharmaceutical Industries Ltd37.006.030.95%
Cipla Ltd23.034.531.06%
Dr Reddy's Laboratories Ltd20.024.010.59%

BIOFILCHEM Stock Price Comparison

Compare BIOFILCHEM with any stock or ETF
Compare BIOFILCHEM with any stock or ETF
BIOFILCHEM
Loading...

BIOFILCHEM Holdings

BIOFILCHEM Shareholdings

BIOFILCHEM Promoter Holdings Trend

BIOFILCHEM Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

BIOFILCHEM Institutional Holdings Trend

BIOFILCHEM Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

BIOFILCHEM Shareholding Pattern

BIOFILCHEM Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding46.82%0.00%0.08%0.00%53.10%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

BIOFILCHEM Shareholding History

BIOFILCHEM Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.03%0.00%0.00%0.00%0.00%

BIOFILCHEM Insider Trades & Bulk Stock Deals

BIOFILCHEM Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing BIOFILCHEM stock

smallcases containing BIOFILCHEM stock

Looks like this stock is not in any smallcase yet.

BIOFILCHEM Events

BIOFILCHEM Events

BIOFILCHEM Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BIOFILCHEM has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

BIOFILCHEM Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BIOFILCHEM has not given any dividends in last 5 years

BIOFILCHEM Dividends

BIOFILCHEM Dividends

Hmm, looks like data is unavailable here. Please come back after some time

BIOFILCHEM Stock News & Opinions

BIOFILCHEM Stock News & Opinions

Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit declines 20.00% in the March 2025 quarter

Net profit of Biofil Chemicals & Pharmaceuticals declined 20.00% to Rs 0.20 crore in the quarter ended March 2025 as against Rs 0.25 crore during the previous quarter ended March 2024. Sales declined 45.07% to Rs 8.35 crore in the quarter ended March 2025 as against Rs 15.20 crore during the previous quarter ended March 2024. For the full year,net profit declined 21.13% to Rs 0.56 crore in the year ended March 2025 as against Rs 0.71 crore during the previous year ended March 2024. Sales declined 16.58% to Rs 33.40 crore in the year ended March 2025 as against Rs 40.04 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales8.3515.20 -45 33.4040.04 -17 OPM %1.32-0.20 -2.542.05 - PBDT0.340.36 -6 1.121.27 -12 PBT0.260.28 -7 0.740.87 -15 NP0.200.25 -20 0.560.71 -21 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to hold board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit rises 77.78% in the December 2024 quarter

Net profit of Biofil Chemicals & Pharmaceuticals rose 77.78% to Rs 0.16 crore in the quarter ended December 2024 as against Rs 0.09 crore during the previous quarter ended December 2023. Sales rose 182.31% to Rs 14.20 crore in the quarter ended December 2024 as against Rs 5.03 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales14.205.03 182 OPM %2.183.78 - PBDT0.320.22 45 PBT0.220.11 100 NP0.160.09 78 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to convene board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit declines 83.33% in the September 2024 quarter

Net profit of Biofil Chemicals & Pharmaceuticals declined 83.33% to Rs 0.02 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales declined 86.13% to Rs 2.41 crore in the quarter ended September 2024 as against Rs 17.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2.4117.37 -86 OPM %4.981.38 - PBDT0.130.26 -50 PBT0.030.15 -80 NP0.020.12 -83 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to conduct board meeting

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals AGM scheduled

Biofil Chemicals & Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
Biofil Chemicals & Pharmaceuticals standalone net profit declines 29.17% in the June 2024 quarter

Net profit of Biofil Chemicals & Pharmaceuticals declined 29.17% to Rs 0.17 crore in the quarter ended June 2024 as against Rs 0.24 crore during the previous quarter ended June 2023. Sales rose 247.33% to Rs 8.44 crore in the quarter ended June 2024 as against Rs 2.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales8.442.43 247 OPM %3.6717.28 - PBDT0.330.43 -23 PBT0.230.32 -28 NP0.170.24 -29 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Biofil Chemicals & Pharmaceuticals to table results

Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Bharat Immunological & Biological Corporation Ltd leads gainers in ‘B’ group

2 years agoBusiness Standard

Frequently asked questions

Frequently asked questions

  1. What is the share price of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) today?

    The share price of BIOFILCHEM as on 13th June 2025 is ₹50.14. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?

    The past returns of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share are
    • Past 1 week: -5.67%
    • Past 1 month: 17.95%
    • Past 3 months: 16.15%
    • Past 6 months: -23.06%
    • Past 1 year: -19.67%
    • Past 3 years: -7.58%
    • Past 5 years: 293.25%

  3. What are the peers or stocks similar to Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM)?

    The peers or stocks similar to Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) include:

  4. What is the market cap of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is ₹81.49 Cr as of 13th June 2025.

  5. What is the 52 week high and low of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) share?

    The 52-week high of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is ₹91.87 and the 52-week low is ₹40.40.

  6. What is the PE and PB ratio of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) stock?

    The P/E (price-to-earnings) ratio of Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) is 145.52. The P/B (price-to-book) ratio is 4.48.

  7. Which sector does Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) belong to?

    Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) shares?

    You can directly buy Biofil Chemicals and Pharmaceuticals Ltd (BIOFILCHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.